Great Novel Therapeutics Biotech & Medicals (TPEX:7427)
Taiwan · Delayed Price · Currency is TWD 33.20
+2.35 (7.62%)
Apr 20, 2026, 1:24 PM CST
TPEX:7427 Market Cap
TPEX:7427 has a market cap or net worth of 1.46 billion as of April 20, 2026. Its market cap has decreased by -30.29% in one year.
Market Cap
1.46B
Enterprise Value
1.02B
Revenue
1.21M
Ranking
n/a
PE Ratio
n/a
Stock Price
33.20
Market Cap Chart
Since July 8, 2021, TPEX:7427's market cap has decreased from 1.48B to 1.46B, a decrease of -1.24%. That is a compound annual growth rate of -0.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 1.33B | -3.59% |
| Dec 31, 2025 | 1.37B | -7.37% |
| Dec 31, 2024 | 1.48B | -42.09% |
| Dec 29, 2023 | 2.56B | 40.55% |
| Dec 30, 2022 | 1.82B | 94.83% |
| Dec 30, 2021 | 935.73M | -36.72% |
| Jul 8, 2021 | 1.48B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GenMont Biotech Incorporation | 1.54B |
| Advagene Biopharma | 1.53B |
| NeoCore Technology | 1.40B |
| Abnova (Taiwan) | 1.36B |
| Enimmune | 1.34B |
| Holy Stone Healthcare | 1.24B |
| Meribank Biotech | 1.16B |
| GeneReach Biotechnology | 1.13B |